Piacentino, Daria
Ogirala, Ajay
Lew, Robert
Loftus, Gregory
Worden, MaryAlice
Koblan, Kenneth S.
Hopkins, Seth C. http://orcid.org/0000-0003-3999-2281
Funding for this research was provided by:
Sumitomo Pharma America, Inc.
Article History
Received: 16 August 2023
Accepted: 21 September 2023
First Online: 19 October 2023
Declarations
:
: Daria Piacentino, Ajay Ogirala, Robert Lew, MaryAlice Worden, Kenneth S. Koblan, and Seth C. Hopkins are employees of Sumitomo Pharma America, Inc. (formerly Sunovion Pharmaceuticals Inc.). Gregory Loftus is an employee of Sumitomo Pharma America, Inc. (formerly Sumitovant Biopharma Inc.). They are supported by funding from Sumitomo Pharma America, Inc. (formerly Sunovion Pharmaceuticals Inc.) and Otsuka Pharmaceuticals Development & Commercialization, Inc.
: This is a secondary analysis of de-identified data from six previously conducted RCTs; thus, it did not require IRB review. Ethics committee information is available in the primary reporting of the studies.